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Vinyl chloride (VC) is an environmental toxicant that directly causes liver injury at high 
concentrations. However, lower concentrations (< OSHA limits), which are not overtly 
hepatotoxic, enhance injury caused by high-fat diet (HFD), at least in part, via mitochondrial 
dysfunction and endoplasmic reticulum (ER) stress. Mitochondria and the ER closely interact via 
mitochondria-associated membranes (MAMs). Alterations in these contact sites are associated 
with mitochondrial dysfunction and ER stress. The purpose of this study was to investigate the 
impact of VC exposure on the damage, function and interaction (via MAMs) of these organelles. 
C57Bl/6J mice, fed HFD, or low-fat control diet (LFD), were exposed to VC (<1 ppm), or room 
air for 6 hrs/d, 5 d/wk for up to 12 wks. Alpha mouse liver 12 (AML12) cells were exposed to the 
VC metabolite, chloroacetaldehyde (CAA) for 20 hrs at 37°C. VC exposure modified 
mitochondrial morphology by increasing mitochondrial area, independent of diet while 
mitochondrial DNA content was unaffected. VC also decreased levels of key MAM complex 
proteins. CAA exposure increased mitochondrial size and altered the proximity between the ER 
and mitochondria in AML12 cells. Taken together, VC and CAA altered mitochondrial structure 
and organelle interactions. These stress responses may be causal in VC-mediated toxicity and 
sensitization. These data highlight that current safety restrictions may be insufficient to address 
VC-induced hepatotoxicity in humans. 
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1.0 Background and rationale for the study 
1.1 Obesity and fatty liver disease 
According to the World Health Organization (WHO) the prevalence of obesity has almost 
tripled since 1975 and there are over 650 million obese individuals worldwide. In the United States, 
34.2% of the adult population is overweight (BMI≥ 25) and 33.8% are obese (BMI≥ 30).1 Obesity 
is associated with detrimental health effects, including cardiovascular disease, type 2 diabetes, and 
metabolic syndrome.2 The major hepatic manifestation of metabolic syndrome is non-alcoholic 
fatty liver disease (NAFLD) and is as such closely correlated with incidence of obesity.  
NAFLD is a spectrum of liver diseases ranging from steatosis, to inflammation, to fibrosis 
and cirrhosis.3 The first stage in the development of NAFLD is characterized by lipid accumulation 
in the liver (steatosis).4, 5 Although eating a diet high in fatty acids is a major player in developing 
NAFLD,6 other risk-factors can promote the progression of NAFLD to more severe forms of liver 
injury such as steatohepatitis and cirrhosis. Such modifying risk factors include genetics, 
comorbidities, and xenobiotics.7 
The idea of multiple ‘hits’ in liver disease has been well-established.8, 9 We propose that 
low-dose vinyl chloride (VC) may serve as a risk-modifying factor in the progression of 
steatohepatitis. Indeed, data by our laboratory demonstrate that VC, at concentrations that are not 
hepatotoxic per se, exacerbates liver damage in animals fed high-fat diet (HFD).10, 11 Importantly, 
VC has recently been shown to be a risk factor for liver disease, independent from other causes.12  
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1.2 Vinyl chloride 
VC is a volatile organic compound (VOC) and can be formed as a degradation product 
from chlorinated chemicals such as trichloroethylene (TCE) and tetrachloroethylene (PCE).13, 14 
VC is used in industry to create the polymer polyvinyl chloride (PVC). Occupational exposure to 
VC occurs in facilities that produce PVC and has affected more than 80,000 American chemical 
workers.15, 16 The annual VC production has been estimated at 27 million metric tons.17 Therefore, 
VOCs are found in significant concentrations in the ambient air surrounding manufacturing 
complexes.14 There is a risk for widespread VC exposure, not only under occupational 
circumstances but also to the general population. The main environmental exposure risk occurs 
from contaminated groundwater in areas surrounding production facilities and superfund 
locations.14 VC is present in landfills and in natural gas fracking fluids that can leak into 
groundwater wells in close proximity.18 For example, up to 1,000,000 individuals (military, 
civilian personnel and their families) at Camp Lejeune alone have been exposed to VC.13 Owing 
to its widespread presence in EPA superfund sites, its usage in industry, and its known potential 
human risk, VC is ranked #4 on the Agency for toxic substance disease registry (ATSDR) 
Hazardous Substance Priority List.19 
VC can be ingested through contaminated ground water; however, it is primarily inhaled. 
VC is rapidly absorbed and widely distributed within the body. The main site for VC metabolism 
is the liver, as a consequence, the liver is sensitive to VC exposure. The liver is responsible for the 
removal of toxic compounds from the body in order to protect other organs from exposure.20 
Within the liver, VC is primarily metabolized by the cytochrome P450 enzyme, CYP2E1. This 
enzyme catalyzes the oxidation of VC to 2-chloroethylene oxide (CEO), a highly reactive epoxide. 
CEO is rearranged to form a reactive aldehyde species, 2-chloroacetaldehyde (CAA). VC can also 
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be oxidized to form 2-chloroethanol (CE), which is metabolized to CAA via alcohol 
dehydrogenase. CAA then enters into a subsequent reaction catalyzed by aldehyde dehydrogenase 
to form chloroacetic acid (Figure 1). VC intermediates are detoxified via conjugation with 
glutathione and excreted as thioacetic acid in the urine.21, 22 VC metabolites are electrophilic and 
attack nucleophilic biomolecules such as lipids, nucleic acids, and proteins.22-25 Work from the 
Beier laboratory has shown that VC metabolites sensitize hepatocytes to injury from a second 
stimulus. Furthermore, sub-hepatoxic doses of CE altered hepatic metabolism and enhanced 
damage when combined with another factor in vivo.26, 27 These pathologic changes were mediated, 
at least in part, via CAA’s direct toxicity to the mitochondria via decreasing mitochondrial 
respiration, depletion of cellular ATP levels, and depolarization of the mitochondrial membrane 
potential.28 
1.3 Vinyl chloride and hepatic injury 
High occupational exposure to VC  causes toxicant-associated steatohepatitis (TASH) in 
human subjects.29-31 TASH is recognized as a unique hepatic disorder with its own etiology and 
pathophysiology.29 Although this direct hepatotoxic effect of VC has been identified, the 
mechanism(s) by which low concentrations of VC enhance hepatotoxicity, have not been 
determined.  
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1.4 Vinyl chloride and mitochondrial function 
Mitochondria are essential to overall function and health of all cell types. They respond 
dynamically to stress signals, nutrient availability and are responsible for many functions within 
the cell, including redox signaling, calcium homeostasis, programmed cell death, and energy 
metabolism through oxidative phosphorylation (OXPHOS). If any of these functions are disrupted, 
cellular processes can become dysfunctional, resulting in biochemical and physiological stress and 
ultimately lead to cell death. Therefore, maintenance and regulation of mitochondrial homeostasis 
is crucial to overall health of an organism.  
It is known that ingestion of a HFD causes mitochondrial metabolic disruption. Mitochondria 
play key roles in hepatic (mal)adaptation to NAFLD; however, the underlying mechanisms are 
incompletely understood. Mitochondrial-driven alterations in substrate supply, metabolism, and 
cell death have been consistently identified as likely players. Indeed, mitochondrial function and 
morphology are known to be altered both in experimental NAFLD and in humans presenting with 
NAFLD and non-alcoholic steatohepatitis (NASH).32, 33 
Mitochondria are a significant source of endogenous reactive oxygen species (ROS), as 
electron leakage occurs during normal oxidative respiration.34, 35  Mitochondrial-generated ROS 
are involved in physiological signaling cascades regulating various cellular functions.34, 35 
However, overproduction of ROS and the resulting oxidative stress are known to play a central 
role in the pathogenesis of many diseases, i.e. NAFLD.36,37 Moreover, our lab has shown that VC 
enhances NAFLD-induced oxidative stress.11, 26 This result suggests that one of the mechanisms 
by which VC exerts damage is by increasing ROS production, resulting in disruption of normal 
cellular funciton and sensitizes the hepatocytes to further damage.  
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1.5 Mitochondrial membrane potential 
Work from the Beier laboratory demonstrated that independent of diet, VC exposure 
significantly decreases mitochondrial respiration and maximum respiratory capacity in 
mitochondria.11 One mechanism by which oxidative phosphorylation is controlled is via the 
mitochondrial membrane potential (MMP), which is generated and maintained by the proton 
pumps of the electron transport chain (ETC) (complexes I, III and IV).38 The MMP and proton 
gradient form an electrical gradient, which together, form the transmembrane potential of 
hydrogen ions used by ATP synthase to form ATP.38 Previous work by our group has demonstrated 
that in vitro exposure to VC metabolites renders hepatocytes more sensitive to cell death.26 
Similarly, VC exposure in vivo decreases mitochondrial membrane potential and sensitizes 
hepatocytes to ex vivo cytotoxic stimuli resulting in cell death. We propose that these effects 
contribute, at least in part, to the overall phenotype. 
1.6 Mitochondrial-associated membranes 
Recent work suggests that stress to mitochondria and the ER is not distinct, but rather that 
mitochondrial/ER crosstalk is critically-involved in normal and altered function in both 
organelles.39-41 Mitochondria and the ER physically interact via specialized contact sites called 
mitochondria-associated membranes (MAMs).42-45 Importantly, MAMs house key components 
that impact cellular and organelle function by regulating and controlling mitochondrial function, 
ER stress signaling and autophagy,40 making them sensitive targets. It has been demonstrated that 
ER-mitochondria interactions are decreased in obese mice,39 leading to ER-mitochondria 
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miscommunication. Therefore, a major goal of this work is to determine the role VC exposure on 
MAMs. 
1.7 Statement of goals 
There are many known risk factors for liver disease progression including nutrient overload 
and toxicant exposure that need to be considered when studying disease development. Due to VC 
being a common industry toxicant and the high prevelance of obesity, these two factors need to be 
considered simultaneously. We aim to demonstrate that low-level VC exposure induces 
morphological and functional changes to the mitochondria and therefore lead to an exacerbation 




Figure 1: Schematic illustration of VC metabolism in the liver. 
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2.0 Overall aim of the thesis 
 The overall aim of this thesis is to address the hypothesis that low- level VC exposure 
(sub-OSHA level) is sufficient to exacerbate mitochondrial dysfunction by altering mitochondrial 
morphology and disrupting mitochondria-ER communication in HFD induced liver disease. 
Recent data from this lab have determined that sub-hepatotoxic concentrations of VC/VC 
metabolites can induce mitochondrial dysfunction by depleting cellular ATP levels and decreasing 
oxygen consumption rate in the mitochondria. Furthermore, VC/VC metabolites increase ER 
stress. Therefore, the effect of sub-OSHA exposure to VC via inhalation on mitochondrial/ ER 
communication via MAMs was assessed. Mitochondrial structure and dynamics are crucial for 
whole cell homeostasis. As discussed in the Background, VC/VC metabolites have been shown to 
disrupt mitochondrial function and respiration. However, the effect on mitochondrial structure and 
integrity has yet to be determined. Thus, this will be addressed in this thesis. Taken together, the 
goal of this thesis is to provide further insight into sub-OSHA exposure of VC and its effect on 
mitochondrial function and integrity.  
 9 
3.0 Introduction 
The current obesity epidemic in the United States is prevalent with over 1/3 of the 
population being considered obese (BMI > 30 mg/km2).46 There are several pathologies associated 
with obesity, including metabolic syndrome with the primary hepatic manifestation of metabolic 
syndrome being non-alcoholic fatty liver disease (NAFLD). The progression and severity of liver 
disease can be enhanced by other factors, such as environmental toxins/toxicants, which are only 
beginning to be understood as an important factor in contributing to the progression of liver 
disease, and the underlying mechanisms.8 Vinyl chloride (VC) is a potent, ubiquitous compound 
in which individuals can be exposed to environmentally or occupationally.47 VC is found as a 
degradation product of other chlorinated chemicals and is direct hepatotoxicant at high 
concentrations.13, 48 29, 49, 50 While most studies focus solely on the effect of VC exposure on human 
health alone, our lab takes into consideration the interaction of low-dose VC with risk-modifying 
factors, such as over nutrition.  
Our recent studies suggest that obesity and hepatic steatosis increase susceptibility to VC, 
making them vulnerable to worse hepatic pathology.10, 26, 27, 51 Since NAFLD is prevalent in the 
developed world,52 our lab is focused on defining the interactions between a high-fat diet (HFD) 
and VC exposure. Our lab has documented that sub-OSHA levels of VC inhalation cause oxidative 
stress and mitochondrial dysfunction leading to disruptions of hepatic energy metabolism and 
steatohepatitis.11 Furthermore, previous data from this group demonstrated that VC exposure leads 
to endoplasmic reticulum (ER) dilation,10 which activates ER stress pathways.53 We hypothesize 
that ER stress and mitochondrial dysfunction in the interaction of VC and HFD causes the 
metabolic derangements of the liver in this model, at least in part, via mitochondrial-ER 
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miscommunication. The purpose of the current study, therefore, was to elucidate the impact of VC 
exposure on the function and interaction (via mitochondria-associated membranes-MAMs) of 
these organelles and to further discern the impact of altered MAM proteins have on mitochondrial 
morphology. 
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4.0 Materials and Methods 
4.1 Animals and Procedures 
Six‐week‐old male C57BL/6J mice from Jackson Laboratory (Bar Harbor, ME) were held 
in a pathogen‐free barrier facility accredited by the Association for Assessment and Accreditation 
of Laboratory Animal Care, and procedures were approved by the local Institutional Animal Care 
and Use Committee. Animals were housed in shoebox cages with corncob bedding and were 
allowed food and water ad libitum on a 12‐hour light/dark cycle. 
4.1.1 Diets 
Low fat diet (LFD). 13% calories as fat; Casein 195.0 g/kg, DL-Methionine 3.0 g/kg, 
Sucrose 120.0 g/kg, Corn Starch 432.89 g/kg, Maltodextrin 100.0 g/kg, Anhydrous Milkfat 37.2 
g/kg, Soybean Oil 12.8 g/kg, Cellulose 50 g/kg, Mineral Mix, AIN-76 (170915) 35.0 g/kg, Calcium 
Carbonate 4.0 g/kg, Vitamin Mix, Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant 0.01 g/kg; 
(Envigo Teklad Diets, Madison, WI). 
High fat diet (HFD). 42% calories as fat; Casein 195.0 g/kg, DL-Methionine 3.0 g/kg, 
Sucrose 341.31 g/kg, Corn Starch 75.0 g/kg, Maltodextrin 75.0 g/kg, Anhydrous Milkfat 210.0 
g/kg, Cholesterol 1.5 g/kg, Cellulose 50.0 g/kg, Mineral Mix, AIN-76 (170915) 35.0 g/kg, Calcium 
Carbonate 4.0 g/kg, Vitamin Mix, Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant 0.04 g/kg; 
(Envigo Teklad Diets, Madison, WI). 
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4.1.2 Chronic model of VC exposure 
The in vivo results generated in this study were used from preexisting samples. The 
exposure paradigm used was modified from Drew et al.54 Mice were chronically exposed to VC at 
0.85 ± 0.1 ppm, or room air, for 6 hours per day, 5 days per week, for a maximum of 12 weeks.54 
Mice were exposed in a state-of-the-art 2-tiered inhalation chamber system capable of performing 
simultaneous exposures with up to 100 mice at one time (50 mice/tier) housed at the University of 
Louisville, in the Clinical Translational Research Building barrier facility designed with extensive 
housing capacity, card-coded entry, and separate HVAC system to maintain barrier, temperature 
and humidity condition.54 Mice were allowed food and water ad libitum the entire course of the 
study. Mice were fed low fat diet or high fat diet (Envigo, Teklad Diets, Madison, WI). Body 
weight for each animal was measured once per week and food consumption was monitored and 
recorded twice per week. Animals were euthanized at 6 and 12 weeks of exposure. 
4.1.3 Key chemicals and resources 
VC obtained from Kin-Tek (La Marque, TX) was validated by the Kentucky Institute for 
the Environment and Sustainable Development of the University of Louisville and was stored at -
20°C in the barrier facility when not in use. The VC concentration in the inhalation chamber was 
measured by gas chromatography/mass spectrometry (GC/MS) in full scan mode according to the 
EPA method TO-15, using a quadrupole GD (HP 6890) with a HP 5973 Mass Selective Detector. 
Grab air samples from the inhalation chamber were collected as the air exited the chamber into 
pre-evacuated six-liter Silcosteel canisters.  
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4.1.4 Animal sacrifice, tissue collection, and storage 
At the time of sacrifice, 4 hour fasted animals were anesthetized with ketamine/xylazine 
(100/15 mg/kg, i.p.). Blood was collected from the inferior vena cava just prior to sacrifice by 
exsanguination and citrated plasma was stored at -80°C for further analysis. Portions of liver tissue 
were snap-frozen in liquid nitrogen, embedded in frozen specimen medium (Sakura Finetek, 
Torrance, CA), or were fixed in 10% neutral buffered formalin for subsequent sectioning and 
mounting on microscope slides.  
4.2 Cell Culture 
  AML12 cells (ATCC # CRL-2254, American Type Culture Collection, Manassas, Virginia) 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) with phenol red, 
supplemented with 10% heat-inactivated fetal bovine serum, 100 IU/ml penicillin, 10 µg/ml 
streptomycin, 10µg/ml insulin, 40ng/ml dexamethasone. Cells were grown in 25-cm2 cell culture 
flasks at 37°C with 5% CO2 in a humidified incubator.  
4.2.1 Mitochondrial Reconstruction 
  For determination of mitochondrial volume changes, mitochondrial reconstruction was 
performed as previously described.55 AML12 cells in 8-well chamber slides were pre-incubated 
for 1 hr with Szeto-Schiller (SS)-31, followed by an incubation with chloroacetaldehyde (CAA) 
for 20 hrs in the presence or absence of SS-31. Cells were fixed in 4% paraformaldehyde (PFA). 
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Fixed cells were stained using anti-TOM20 (Invitrogen, PA5-52843) to label the mitochondria. 
Cells were co-stained with DAPI (nuclei). Confocal z-stacks were collected using 60X (1.49NA) 
optic on a Nikon A1 equipped with GASP detectors and NIS Elements software (Nikon Inc., 
Melville NY). The confocal datasets were deconvoluted using 3D Landweber capabilities of 
Nikon Elements (Nikon Inc., Melville, NY) and then surface rendering and calculation of 
mitochondrial volume were collected.  
4.2.2 Proximity Ligation Assay (PLA) 
PLA was performed as described previously.56, 57 AML12 cells were fixed in 4% PFA. 
Samples were incubated with anti-Tom20 (Invitrogen, PA5-52843) primary antibody at room 
temperature for 1 hr then incubated with anti-Calnexin (Invitrogen, MA3-027) primary antibody 
at 4°C overnight. Secondary antibodies conjugated with oligonucleotides were added to the 
reaction and incubated at 37°C for 1 hr. Ligation solution, consisting of two oligonucleotides and 
ligase, was added and incubated at 37°C for 45 min. In this assay, the oligonucleotides hybridize 
to the two PLA probes on the secondary antibodies and join to a closed loop if they are within 40 
nm of each other. Amplification solution, consisting of nucleotides and fluorescently labeled 
oligonucleotides, was added together with polymerase and incubated at 37°C for 1 hr and 40 min. 
The proximity ligated signal is visible as a distinct fluorescent spot and confocal images were 
collected using 60X (1.49NA) optic on a Nikon A1 equipped with GASP detectors and NIS 
Elements software (Nikon Inc., Melville NY). The confocal datasets were deconvoluted using 3D 
Landweber capabilities of Nikon Elements (Nikon Inc., Melville, NY). Then deconvoluted 
confocal images were analyzed using NIS elements (Duolink; Sigma Aldrich).  
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4.3 Electron Microscopy (EM) 
EM analysis was performed as previously described.58 Briefly, liver tissues were fixed with 
2.5% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.4), followed by 1% OsO4. After 
dehydration, thin sections were stained with uranyl acetate and lead citrate for observation under 
a JEM 1011CX electron microscope (JEOL). Images were acquired digitally at the University of 
Kansas Medical Center. 
4.4 Immunoblots 
Liver samples were homogenized in buffer containing protease and phosphatase inhibitor 
cocktails (Sigma-Aldrich, St. Louis, MO) as previously described.59 Sodium dodecyl sulfate–
polyacrylamide gel electrophoresis was followed by Western blotting. Primary antibodies against 
MFN2 (ab56889), Disc-1 (ab192258), Calnexin (ab22595) (1:1,000, Abcam, Cambridge, MA), 
OPA1 (80471), GRP75 (3593), DRP1 (8570), SERCA (4388), glyceraldehyde 3‐phospohate 
dehydrogenase (GAPDH) (5174s) (1:1,000, Cell Signaling Technologies, Danvers, MA), and 
IP3R-1 (1:1,000, Invitrogen, PA1-901) were used. Results were visualized using the iBright 1500 
imager (Thermo Fisher Scientific, Waltham, MA). Densitometric analysis was performed using 
iBright analysis software (Thermo Fisher Scientific, Waltham, MA).  
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4.5 Statistical Analysis 
Power analysis was used to calculate the number of animals required for the experiments. 
Based on previous studies and preliminary data, we estimated that we needed a minimum of five 
animals per group to compare the primary endpoint (i.e., levels of organ injury) in HFD and VC‐
exposed mice to get an 85% power for detecting a difference of at least 20% with P < 0.05 between 
experimental groups. Results are reported as means ± SEM (n = 4‐12). Analysis of variance with 
Bonferroni's post‐hoc test (for parametric data) or Mann–Whitney Rank Sum test (for 
nonparametric data) were used for the determination of statistical significance among treatment 
groups, as appropriate. P < 0.05 was selected before the study as the level of significance. 
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5.0 Results 
5.1 In vivo studies 
5.1.1 VC induces enlarged mitochondria 
Our lab has previously shown that liver injury caused by HFD can be enhanced by sub-
hepatotoxic concentrations of VC or its metabolites, in part, by dysregulating hepatic energy 
metabolism and decreasing respiration.10, 27, 51 Altered mitochondrial integrity has been shown to 
cause an overall decrease in respiration.60 It is now known that mitochondrial integrity not only 
encompasses functional but also structural attributes.61 Analysis of EM pictures demonstrated that 
overall area of the mitochondria was significantly increased by VC alone (Figure 2B), while 
remaining spherical (length/width ratio, Figures 2B and 2C). Moreover, VC alone significantly 
increased the length/width ratio of the mitochondria (Figure 2B). In line with previous reports,62 
morphometric analysis of these mitochondria showed that HFD caused an elongation of the 
mitochondria. Furthermore, HFD+VC dramatically altered this morphology resulting in strongly 
enlarged, spherical mitochondria (Figure 2A). Interestingly, the ratio of mitochondrial to nuclear 




Figure 2: Effect of VC on mitochondrial morphology. A: Representative EM photomicrographs 
depict elongated organelles in the HFD group and enlarged mitochondria (width, length >1 mm) 
in the HFD+VC group. Arrow denotes mitochondria, LD denotes lipid droplet, and N denotes 
nucleus. B: Total mitochondrial area (µm2) and mitochondrial length/width ratio are shown. C: 
Distribution of the size of 70 mitochondria/group is shown. D: Hepatic mRNA expression of 
mitochondrial DNA is shown as fold of control compared to LFD control animals at the 6-week 
time point. a, p<0.05 compared to LFD control; b, p<0.05 compared to absence of VC. Samples 
size per group n =8-10. 
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5.1.2 VC alters protein levels of mitochondrial-associated membranes (MAMs) 
The mitochondria and ER physically interact with each other through MAMs (Figure 3A). 
MAMs, are key to cell survival or death through the transfer of calcium, proteins, and lipids.63 Our 
lab has shown that VC induces ER stress and causes mitochondrial dysfunction.11 We hypothesize 
that VC causes this effect, in part, by disrupting proper communication between these organelles 
via MAM proteins. To investigate if VC impacts ER-mitochondria interactions through altering 
protein levels of MAMs, whole liver lysates and mitochondrial extracts were used for Western blot 
analyses. The expression of Calnexin, Ip3R1, Serca, and Disc-1 (all localized on the ER), Grp75 
(localized on the ER and mitochondria), as well as Opa1, Mfn2 and Drp1 (all localized on the 
mitochondria) were analyzed. These proteins are involved in Ca2+ transport, protein assembly, 
mitochondrial fission and fusion, and integration of ER-mitochondrial communication, ER 
homeostasis and autophagy. In isolated mitochondrial extracts, VC alone did not significantly 
change the protein expression. However, HFD increased MAM protein expression in these 
samples (Figure 3C). VC exposure blunted HFD induced expression of these markers. In whole 
liver lysates, VC alone significantly increased Mfn2 expression, required for mitochondrial fusion 
(Figure 3B). These data support our hypothesis that VC exposure alters mitochondrial 
morphology.  
MAMs are important for mitochondrial dynamics by marking sites of mitochondrial fission 
and fusion; that is the joining and separating of the organelle.64 The balance of mitochondrial 
fission and fusion is imperative for regulating mitochondrial bioenergetics and removing damage 
during periods of internal stress.65, 66 We hypothesize that the HFD and VC interaction further 
disrupts mitochondrial fission and fusion processes by increasing fusion and decreasing fission, 
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Figure 3: VC alters MAMs protein levels. A: Schematic illustration of functional and structural 
MAM proteins. B: Representative Western blots and densitometric analysis for whole liver lysates 
of Mfn2, Disc-1, Opa1, Grp75, Drp1, and Serca are shown and C: Western blots of crude 
mitochondrial extracts of Calnexin, Grp75, IP3R-1, and Drp1 are shown. a, p<0.05 compared to 
LFD control; b, p<0.05 compared to absence of VC. Samples size per group n =4. 
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5.2 In vitro studies 
5.2.1 Chloroacetaldehyde (CAA) increases mitochondrial size 
Mitochondria are highly dynamic and functionally versatile organelles that fuse and 
fragment continuously. The morphology of mitochondria (fragmented and extensive fusion) has 
been shown to strongly influence mitochondrial function.67 To determine if VC/VC metabolite 
exposure causes morphologic changes, mitochondrial reconstruction was performed. AML12 cells 
were incubated with CAA (0µM- 20µM) for 20 hrs. Exposure to CAA significantly increased 
mitochondrial volume at low concentrations (≤ 2.5 µM) up to 10 µM of CAA in a concentration-
dependent manner (Figure 4B). The mitochondrial phospholipid, cardiolipin, plays a central role 
in many mitochondrial processes, including mitochondrial morphology and dynamics.68-70 SS-31 
is a mitochondrial specific peptide that has been shown to selectively bind to cardiolipin on the 
inner mitochondrial membrane. We hypothesize that VC/VC metabolites destabilize cardiolipin 
leading to altered mitochondrial morphology and that stabilization of cardiolipin with SS-31 
treatment will attenuate the increase in mitochondrial volume caused by CAA exposure. AML12 
cells were pre-treated with 1µM of SS-31 for 1 hr, then cells were exposed to CAA ± 1µM of SS-
31 for 20 hrs and mitochondrial reconstruction was performed. Increasing concentrations of CAA 
increased mitochondrial volume in a dose dependent manner. Addition of SS-31 mitigated this 
effect at lower concentrations, but did not compensate past 10µM (Figure 4B). 
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Figure 4: Effect of CAA on mitochondrial volume. AML12 cells were grown on 8-well chamber 
slides and incubated with 0µM, 1µM, 2.5µM, 5µM, and 10µM of CAA ± 1µM of SS-31 for 20 
hrs. A: Confocal microscopy images of mitochondria (red) from AML12 cells. B: Images were 
deconvoluted to better enable resolution of individual mitochondria. Mitochondrial volume was 
quantified by multiplying the number of voxels by the voxel volume and expressed as fold of 
control and as µm3/ cell. a, p<0.05 compared with absence of CAA. b, p<0.05 compared with 
absence of SS-31. n =3. 
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5.2.2 CAA alters the proximity between the ER and mitochondria  
The mitochondria and ER are both essential to the cell and proper communication of these 
organelles requires close proximity. Dysfunction of either organelle, or a change in proximity, can 
disrupt metabolite transport, lipid metabolism, and induce apoptosis.41 Data from our lab illustrated 
that VC/VC metabolites changed MAM protein expression (Figure 3), increased mitochondrial 
size (Figure 2) and volume (Figure 4), and induced ER stress in vivo.11 In order to determine if the 
VC metabolite, CAA, affects the distance between the ER and mitochondria, AML12 cells were 
incubated with 0µM- 10µM of CAA and a proximity ligation assay (PLA) was performed. Tom20 
antibody was used to label the mitochondria and Calnexin antibody was used to label the ER. 
AML12 incubated with 2.5µM of CAA significantly decreased the distance between the ER and 
mitochondria as imaged by using confocal microscopy and measured by analyzing the overall 
number of puncta per cell (Figure 5B). However, as the CAA concentration increased the distance 




Figure 5: CAA alters the distance between the mitochondria and ER. AML12 cells were 
grown on coverslips and incubated with 0µM, 2.5µM, 5µM, and 10µM, of CAA for 20 hrs. A: 
Proximity ligation assay showing interaction between mitochondria (TOM20) and ER (Calnexin), 
indicated by green puncta. B: Quantification of the mitochondrial-ER proximity ligation signal 





Occupational exposure levels to VC have been regulated since the 1970’s. While these 
regulations lessen concerns about direct hepatotoxicity of high occupational exposure to VC, we 
have demonstrated that lower exposure levels of VC and metabolites that are not overtly toxic, per 
se, can augment liver injury caused by another insult.10, 26, 27 Although low VC exposure alone did 
not cause overt pathology, it damaged mitochondria, leading to decreased oxygen consumption 
rates (OCR) in hepatocytes.10 Mitochondria have been identified to play key roles in hepatic 
(mal)adaptation to NAFLD. Indeed, mitochondrial function and morphology are known to be 
altered both in experimental NAFLD and in humans presenting with NAFLD and NASH.32, 33 
Although the underlying mechanisms are incompletely understood, mitochondrial-driven 
alterations in substrate supply, metabolism, and cell death have been consistently identified as 
likely players. We hypothesize that VC-induced mitochondrial damage may impede the liver’s 
ability to appropriately adapt to the biochemical stresses caused by experimental NAFLD and 
thereby exacerbate damage. The findings of the current study support this hypothesis. We have 
demonstrated here that VC causes significant architectural changes to the mitochondria, even in 
the absence of HFD (Figure 2). This may, in part, be mediated by changes in organelle interaction 
(Figure 3). The major goal of this thesis was too further decern the mechanistic impact on the ER 
and mitochondria following VC-induced liver injury. 
Recent studies have indicated that altered mitochondrial morphology may be a key 
mechanism in mitochondria-mediated cellular injury. Mitochondrial morphology and functionality 
are strictly correlated, and mitochondrial dynamics are constantly adjusting mitochondrial shape 
to maintain homeostasis.71 However, these responses can also be dysfunctional, and drive 
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pathogenesis. Changes in mitochondrial morphology caused by different insults (e.g., fatty diets 
or alcohol), are mediated, at least in part, by mitochondrial remodeling, including elongation or 
overall enlargement of the mitochondria.61, 62 Enlarged mitochondria can be caused by fusion (i.e. 
mitochondrial hypertrophy), or by mitochondrial swelling.72, 73 Mitochondrial hypertrophy is 
associated with normal cristae, normal matrix density and normal oxidative phosphorylation, 
whereas mitochondrial swelling is associated with abnormal cristae, irregular matrix density and 
uncoupled oxidative phosphorylation. In the current model, VC exposure significantly changed 
mitochondrial shape (Figure 2) towards a more spherical morphology, suggesting swelling more 
than hypertrophy. Furthermore, VC metabolite CAA significantly increased mitochondrial volume 
in AML12 cells (Figure 4), also suggesting an enlargement of the mitochondria. However, 
additional experiments are needed to determine whether these results are due to mitochondrial 
swelling or hypertrophy.  
The mitochondrial structural changes observed under these conditions correlated with 
altered function. We have demonstrated that liver injury enhanced by VC is associated with VC-
induced mitochondrial dysfunction, leading to increases in oxidative stress and energy 
dysmetabolism, which was demonstrated by significantly decreasing the oxygen consumption 
rate.10 One of the possible mechanisms of VC-induced changes to mitochondrial respiration is via 
decreased protein expression of electron transport chain complexes. Moreover, mtDNA content, 
which is known to be increased in experimental NAFLD, was not altered following VC exposure 
(Figure 2D). These data suggest, that VC induces post-translational modifications, which results 
in mitochondrial dysfunction rather than directly impacting the mtDNA copy number.  
Mitochondrial quality and abundance affect the cell’s bioenergetic capacity and overall 
resistance to stress.74 Mitochondrial damage has also been linked to the induction of ER stress, 
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which can indirectly affect cellular function. In particular, the ER regulates fundamental 
metabolites (e.g., lipids) and messengers (e.g., Ca2+) that control mitochondrial function and the 
fate of the cell,  suggesting mitochondrial stress is closely associated with ER stress.42 
Mitochondria and the ER also physically interact via specialized contact sites called mitochondria-
associated membranes (MAMs).42-45 It has been demonstrated that ER-mitochondria interactions 
are decreased during obesity (i.e., in ob/ob mice),39 leading to ER-mitochondria 
miscommunication. VC exposure has previously been shown to cause ER stress and mitochondrial 
dysfunction.11, 51, 75, 76 Here, we show in mitochondrial extracts that VC exposure decreases 
expression of proteins involved in ER-mitochondria interaction, including ER-associated proteins 
(Figure 3B and 3C), suggesting a decrease in physical contact and resulting in potential 
miscommunication, ER stress, and mitochondrial dysfunction. However, 2.5 µM of CAA 
decreased the proximity between the mitochondria and ER (Figure 5). Increasing concentrations 
of CAA, including 5µM and 10µM, showed no significant difference when compared to control. 
These results could be explained by the increase in mitochondrial volume seen in CAA-exposed 
cells.  
Taken together, our results support the hypothesis that low-level (sub-OSHA limit) VC 
exposure via inhalation enhances liver injury caused by HFD, mechanistically involving 
structurally and functionally dysregulated mitochondria and their interactions with the ER. 
Importantly, these data raise concerns about potential synergistic effects of fatty diets and exposure 
to VC to enhanced liver injury. Thus, the health implications of this co-exposure for humans need 
to be considered. It also indicates that current safety restrictions may be insufficient to account for 
other environmental factors that can influence hepatotoxicity. 
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7.0 Strengths and Weaknesses 
7.1 Strengths  
 There are many strengths of the work presented in this thesis. This work utilized a well-
established animal model that closely mimics human exposure to VC and concomitant exposure 
to a high fat diet. With this animal model, a chronic administration of sub-OSHA concentrations 
of VC was used. The in vivo results showed here illustrate the importance for continued research 
using relevant exposure concentrations to better understand the impact of environmental toxicants 
have on underlying liver disease. The work presented here builds on previous data and further 
supports the hypothesis that VC exacerbates liver injury induced by HFD by causing mitochondrial 
dysfunction. This research further demonstrates VC-induced mitochondrial dysfunction by 
altering mitochondrial architecture and disrupting communication of the mitochondria with other 
organelles. This work utilized both in vitro and in vivo models to illustrate that VC/VC metabolite 
exposure induces architectural changes to the mitochondria which, in part, leads to mitochondrial 
dysfunction.  
7.2 Weaknesses 
 This research builds on previous work illustrating VC-enhanced liver injury in order to 
further determine the mechanism of VC induced hepatotoxicity. The experiments described here 
in which mitochondrial protein are analyzed used only crude mitochondrial extracts. Therefore, it 
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is important to note that isolating pure mitochondria may yield different results. Furthermore, 
isolation of the ER would also be beneficial to fully discern VC impact on MAMs. While the in 
vivo parts of this thesis used an animal model that is comparable to human exposure, the in vitro 
data would need to be recapitulated in the in vivo model or in primary hepatocytes in order for the 
results to be more comparable to human studies. Lastly, the higher concentrations of CAA may be 
increasing the distance between these organelles and the PLA fails to provide that information. 
The PLA has a limitation that it can only detect within a 40nm and will not detect any changes in 
proximity beyond that distance. Furthermore, while CAA alters the proximity, future experiments 
will need to be performed to explore the mechanistic impact of this alteration. 
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8.0 Future Directions  
 While the experiments in this thesis aided in our understanding of chronic, low-level VC-
induced liver injury, it has also led to new research questions which need to be addressed in future 
studies. Some of these questions are addressed below.  
8.1 Does VC exacerbate mitochondrial dysfunction via dysregulation of cardiolipin?  
 This thesis demonstrated that VC exposure alters mitochondrial morphology causing 
enlarged, spherical mitochondria. Morphometric analysis of these mitochondria demonstrated that 
the overall area of the mitochondria was increased by VC, independent of diet. Previous data 
showed that VC also caused mitochondrial dysfunction.11 The mitochondrial phospholipid, 
cardiolipin, has been shown to have a central role in several mitochondrial processes, including 
respiration, energy production, apoptosis, morphology, and stability.69, 70, 77-80 It has also been 
shown to play a key role in mitochondrial dynamics (fission and fusion), which drive organelle 
morphology and size.80-82 Based on the previous data and the observations of this thesis, it would 
be of interest to determine if the VC-induced mitochondrial dysfunction and changes in 
mitochondrial morphology are caused, at least in part, by dysregulation of cardiolipin as 
destabilized cardiolipin has been shown to cause instability of the membrane and increase 
mitochondrial size.83 
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8.2 Will prevention of altered mitochondrial morphology protect against VC-induces 
hepatotoxicity?  
 Results from this thesis illustrate that VC-induced mitochondrial morphological changes 
may be a driving factor in liver injury progression. Therefore, it would be of interest to determine 
if preventive measures could be taken to mitigate injury progression in this model. There are 
several mitochondrial specific small molecules being studied due to their ability to prevent injury. 
One of these molecules is SS-31, which is a water-soluble peptide, which directly targets the 
mitochondrial membrane.84, 85 It can access the inner mitochondrial membrane and selectively bind 
to cardiolipin. The interaction of SS-31 and cardiolipin has been shown to reduce ROS production 
while also stabilizing the ETC supercomplexes and increases respiratory function through 
oxidative phosphorylation.84, 85 Therefore, it would be of interest to determine if the hepatotoxicity 
induced by the combination of VC and HFD can be attenuated by this molecule.  
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9.0 Summary and Conclusions 
 Taken together, this thesis supports the hypothesis that low-level (sub-OSHA-limit) chronic 
exposure to VC via inhalation enhances liver injury caused by HFD, mechanistically involving 
structural, functional and dynamically dysregulated mitochondria and their interactions with other 
organelles. Furthermore, this thesis illustrates that VC metabolite, CAA, induced architectural 
changes to the mitochondria. This research provides potential mechanisms by which injury can be 
exacerbated following VC/VC metabolite exposure. Importantly, these data raise concerns about 
potential for overlap between fatty diets and exposure to VC and the health implications of this 
co-exposure for humans. It also emphasizes that current safety restrictions may be insufficient to 
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